Overview
LungQ AI software for thoracic CT analysis including lobe and airway segmentation, perfusion defect estimation (PXT), and endobronchial implant detection supporting pulmonary interventions and clinical trials.
Product and company
Thirona — Medical Imaging is a verified product offering linked to the Brel Digital company profile for Thirona.
Use cases
LungQ AI software for thoracic CT analysis including lobe and airway segmentation, perfusion defect estimation (PXT), and endobronchial implant detection supporting pulmonary interventions and clinical trials.
Target customer
Hospitals, interventional pulmonology programs, MedTech partners, and pharma respiratory trials needing quantitative lung imaging biomarkers with FDA and CE regulatory paths.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://thirona.eu/lungq4-receives-fda-510k-clearance/
- Supporting source: https://thirona.eu/about-us/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- LungQ AI software for thoracic CT analysis including lobe and airway segmentation, perfusion defect estimation (PXT), and
- airway segmentation
- perfusion defect estimation (PXT)
- and endobronchial implant detection supporting pulmonary interventions
- clinical trials
Extracted from the linked company product description already verified on Brel. No capabilities were invented.